HealthCare Middle East & Africa Magazine News-WEEK43

AFRICAN ?NEWS HEADLINES ?

WHO, USAID donate medical supplies to boost Kenya’s NTD fight

KENYA— The World Health Organization (WHO), USAID, and other health partners have jointly donated 15,215,000 tablets valued at US$1.7 million, to boost Kenya’s fight against neglected tropical diseases (NTDs). . .More

US provides US$4.1M to aid Uganda’s Mpox response

UGANDA—The U.S. government has announced a significant contribution of US$4.1 million (UGX 15 billion) and 5,500 mpox test kits to aid Uganda’s response to the ongoing mpox outbreak. . .More

WACS accredits Mercy Ships’ training programs

SIERRA LEONE—The West African College of Surgeons (WACS) has accredited Mercy Ships' surgical and anaesthesia training programs in the region. . .More

EU commits additional US$22M to support Mpox outbreak?

ETHIOPIA—The European Union (EU) has pledged an additional €20 million (US$21.71 million) in funding to support efforts to combat the Mpox outbreak in the Democratic Republic of the Congo (DRC). . .More

MIDDLE EAST NEWS HEADLINES ?

Kenya’s Archimedes Motari among top 10 nursing award finalists

UAE—The Aster Guardians Global Nursing Award has named Archimedes Motari from Kenya as one of the top 10 finalists for its prestigious 2024 edition. . .More

RCSI Bahrain announces US$45M Campus expansion

BAHRAIN—The Royal College of Surgeons in Ireland—Medical University of Bahrain (RCSI Bahrain) has announced a significant campus expansion project worth US$45 million, coinciding with its 20th anniversary celebrations. . .More

Burjeel Holdings expands primary care network with nine new clinics

UAE—Burjeel Holdings, a prominent healthcare provider in the MENA region, has unveiled plans to launch nine new primary care clinics in key locations in Abu Dhabi, Al Ain, and Dubai. . .More

WORLD NEWS HEADLINES

Health Canada approves DAYBUE for Rett Syndrome

CANADA—Health Canada has granted Acadia Pharmaceuticals marketing authorisation for DAYBUE (trofinetide), which is intended to treat Rett syndrome in adults and children aged two years and above. . .More

Lundbeck acquires Longboard Pharmaceuticals for US$2.6B

DENMARK—Danish pharmaceutical giant Lundbeck has announced its acquisition of Longboard Pharmaceuticals, a US-based company valued at approximately US$2.6 billion. . .More

Bayer submits Elinzanetant to EMA for non-hormonal menopause treatment

GERMANY—Bayer, the German pharmaceutical giant, has submitted a marketing authorisation application to the European Medicines Agency (EMA) for elinzanetant, a new treatment for menopause-related symptoms. . .More